More than 40 plants have been banned by the FDA for issues ranging from data fraud to hygiene since India's then-largest drugmaker Ranbaxy was pulled up for serious violations in 2008
Read More
Zydus today (5 July,2017) has announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia- inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated with chronic kidney disease (CKD).
Read More
In ICRA’s view, continued regulatory interventions in domestic market will put some pressure in near term though long term growth prospects remain healthy given increasing penetration, accessibility and continued new launches by players.
Read More
The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the GST implementation.
Read More
Armed with investment in R&D and innovation, India Inc. is now betting big on healing with herbs
Read More
Anemia is a leading cause of maternal deaths in India. In India, half of children under three are either stunted or underweight due to malnutrition, and 79 percent are anemic.
Read More
Indian drug industry losses another doyen after Dr. Parvinder Singh, IA Modi and Ramanbhai Patel
Read More
